The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreAs seen on nocamels.com
Ra’anana-based Inspira Technologies (opens in a new tab) today announced the signing of a non-binding Letter of Intent with Shamir Medical Center (opens in a new tab) (Assaf Harofeh), a step the company hopes will lead to providing better respiratory care both here in Israel and in the global community.
“With the anticipated FDA approval on the horizon, I am confident that this prospective collaboration with Shamir Medical Center will enhance the efficacy of life-support care and establish a pathway for its adoption in both local and international markets,” president of Inspira Technologies Joe Hayo said in a press release.
The Letter of Intent (LOI) with Shamir will test the performance of the INSPIRA ART100, an innovative blood oxygenation technology that directly oxygenates blood and immediately elevates and stabilizes patient oxygen levels, in a real-world clinical environment. The LOI hinges on the approval by the Israeli Ministry of Health.
Inspira Technologies CTO Daniella Yeheskely-Hayon is a Technion alumna.